Blair Anger

Blair Anger is currently the Executive Director of Bioprocess Clinical Manufacturing and Technology at Merck, where they lead a GMP clinical manufacturing organization responsible for production across various modalities for vaccines and biologics. Previously, Blair held multiple roles at Merck, including Director and Principal Scientist, focusing on biologics and vaccines strategic operations, and was involved in project management, technology transfer, and process optimization. Blair earned a Bachelor of Science in Biology and Biochemistry from Penn State University and a Master of Business Administration from Villanova University.